EPS SURA requests exit from the Colombian Health Social Security System.
🏥 EPS SURA requests exit from the Colombian Health Social Security System. Learn all about this request. We tell you here 🔍
The unmet need for new drugs against insomnia.
🌙💊 Every night, millions of people struggle to find restful sleep. In a world where treatment options for insomnia have been limited and come with unwanted side effects, the need for new alternatives is more urgent than ever and challenges us to find more effective and safer solutions. How can we improve the quality of sleep and the lives of those who suffer from it? 😴 Here, we explore the unmet need for new insomnia medications. From advances in dual orexin receptor antagonists to products in late-stage development, there is hope on the horizon.
Diabetes treatments, their origins and evolution.
Exceso de azúcar en la sangre… Descubre los orígenes y evolución de los tratamientos para la diabetes.
Passage through the Suez Canal, a victim of world order.
The Suez Canal is affected by rebel attacks. Learn how the Yemenis impacted the Red Sea, causing navigation and transport volumes to decrease considerably.
India leads FDA registrations with 376 new facilities by 2024.
Thus, India Leads FDA Registrations with 376 New Facilities for 2024. Find out why it holds first place above the United States and China.
Invima speeds up procedures due to the problem of backlog of applications.
Invima's Strategies to Streamline its Processes Amidst the Backlog of Applications. Discover what they are and how they impact its management to improve access to essential medicines.
Germán Velásquez takes office as the new director of Invima.
Germán Velásquez is the new Director of Invima! With extensive experience at the WHO and a distinguished international career, Velásquez assumes a crucial role amidst challenges such as drug shortages. His exceptional profile and previous contributions to public health promise solid leadership.
Rheumatoid arthritis, a disease that impacts Colombians.
Discover the reality of Rheumatoid Arthritis in Colombia. The national registry reveals impactful data! Who are the most affected, and what is the path toward a better quality of life?
Recommended: Pains that deceive.
Can you distinguish chest pain that is a sign of a heart attack from one that is NOT? Inform yourself in a vital way about the causes behind this symptom. Stay alert to care for your cardiovascular health!
Indefinite health registrations: Invima aims to extend their validity.
Innovation in Pharmaceutical Regulation! Discover how Invima is optimizing drug approval processes with Decrees 334 of 2022 and 1474 of 2023✔